A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal Obesity

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

December 31, 1998

Study Completion Date

January 31, 2002

Conditions
Obesity
Interventions
DRUG

topiramate

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00231608 - A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal Obesity | Biotech Hunter | Biotech Hunter